Literature DB >> 3618730

Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice.

M F Lipscomb, T Alvarellos, G B Toews, R Tompkins, Z Evans, G Koo, V Kumar.   

Abstract

Previous studies have suggested a possible role for natural killer (NK) cells in resistance to some fungal infections, including Cryptococcus neoformans infections. The role of NK cells in early clearance of C neoformans from tissues and in long-term survival was studied in mice following intravenous inoculations of the organism. Mice treated with anti-asialo GM1 antiserum to temporarily reduce NK activity demonstrated an increase in colony-forming units (CFU) of C neoformans in the lung 24 hours after an intravenous inoculation of the organism. CFU in liver, spleen, kidney, and brain were not different in anti-asialo GM1 antiserum-treated versus control mice. An NK-specific reagent, anti-NK 1.1 monoclonal antibody, was used to deplete mice of NK cells in vivo for at least 14 days without affecting other natural defenses. The number of C neoformans retained in the lungs 24 hours after inoculation of the organism was significantly greater in NK cell-depleted mice than in controls, although CFU in other organs were unaffected. Following the intravenous inoculation of C neoformans, the survival of anti-NK 1.1-treated mice was not different from control mice. The effect of NK cell activity on resistance to C neoformans was also determined after an intratracheal inoculation of the organism. Mice pretreated with anti-NK 1.1 demonstrated no increases in CFU in the lungs, spleen, or brain as compared with controls. These data indicate that NK cells can play a role in vivo in early resistance against C neoformans if the organism is delivered via the intravenous route. However, NK cells do not play a role in either determining survival after an intravenous inoculation nor in resistance during an infection acquired via the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3618730      PMCID: PMC1899629     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans.

Authors:  J W Murphy; D O McDaniel
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

2.  Establishment of monoclonal anti-Nk-1.1 antibody.

Authors:  G C Koo; J R Peppard
Journal:  Hybridoma       Date:  1984

3.  Defective T-cell response in beige mutant mice.

Authors:  R K Saxena; Q B Saxena; W H Adler
Journal:  Nature       Date:  1982-01-21       Impact factor: 49.962

4.  Cryptococcosis in the acquired immunodeficiency syndrome.

Authors:  J A Kovacs; A A Kovacs; M Polis; W C Wright; V J Gill; C U Tuazon; E P Gelmann; H C Lane; R Longfield; G Overturf
Journal:  Ann Intern Med       Date:  1985-10       Impact factor: 25.391

5.  Natural cellular resistance of beige mice against Cryptococcus neoformans.

Authors:  M R Hidore; J W Murphy
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

6.  Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.

Authors:  J Stein-Streilein; M Bennett; D Mann; V Kumar
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

7.  Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.

Authors:  M R Hidore; J W Murphy
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection.

Authors:  J Stein-Streilein; J Guffee
Journal:  J Immunol       Date:  1986-02-15       Impact factor: 5.422

9.  Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.

Authors:  J Hackett; M Tutt; M Lipscomb; M Bennett; G Koo; V Kumar
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

10.  Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice.

Authors:  G Marquis; S Montplaisir; M Pelletier; S Mousseau; P Auger
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

View more
  35 in total

1.  Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.

Authors:  M F Miller; T G Mitchell; W J Storkus; J R Dawson
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Toll-like receptor 9-dependent activation of bone marrow-derived dendritic cells by URA5 DNA from Cryptococcus neoformans.

Authors:  Misuzu Tanaka; Keiko Ishii; Yuri Nakamura; Akiko Miyazato; Atsuko Maki; Yuzuru Abe; Tomomitsu Miyasaka; Hideki Yamamoto; Yukiko Akahori; Misaki Fue; Yurie Takahashi; Emi Kanno; Ryoko Maruyama; Kazuyoshi Kawakami
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

3.  A T cell-independent protective host response against Cryptococcus neoformans expressed at the primary site of infection in the lung.

Authors:  J O Hill; P L Dunn
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

4.  CpG oligodeoxynucleotides promote the host protective response against infection with Cryptococcus neoformans through induction of interferon-gamma production by CD4+ T cells.

Authors:  K Miyagi; K Kawakami; Y Kinjo; K Uezu; T Kinjo; K Nakamura; A Saito
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

5.  STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Karen L Wozniak; Michal A Olszewski; Mathias Mueller; Floyd L Wormley
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

6.  Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.

Authors:  S M Levitz; M P Dupont
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans.

Authors:  Lena J Heung; Tobias M Hohl
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

8.  Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans.

Authors:  J W Murphy; M R Hidore; S C Wong
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans.

Authors:  C H Mody; G H Chen; C Jackson; J L Curtis; G B Toews
Journal:  Mycopathologia       Date:  1994-01       Impact factor: 2.574

10.  Protective murine monoclonal antibodies to Cryptococcus neoformans.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.